As of 2024-12-12, the Intrinsic Value of Cullinan Oncology Inc (CGEM) is
-12.33 USD. This CGEM valuation is based on the model Peter Lynch Fair Value.
With the current market price of 12.52 USD, the upside of Cullinan Oncology Inc is
-198.44%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-12.33 USD
Intrinsic Value
CGEM Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-12.33 - -12.33 |
-12.33 |
-198.44% |
| P/E |
(53.20) - (49.65) |
(56.82) |
-553.8% |
| DDM - Stable |
(12.03) - (26.70) |
(19.37) |
-254.7% |
| DDM - Multi |
(11.00) - (19.35) |
(14.06) |
-212.3% |
CGEM Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
729.04 |
| Beta |
1.83 |
| Outstanding shares (mil) |
58.23 |
| Enterprise Value (mil) |
626.95 |
| Market risk premium |
4.60% |
| Cost of Equity |
15.33% |
| Cost of Debt |
5.00% |
| WACC |
9.50% |